ArticleCells2019
CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate.
Martin Vališ, Lukáš Sobíšek, Oldřich Vyšata, Blanka Klímová, Ctirad Andrýs, Doris Vokurková, Jiří Masopust, Zbyšek Pavelek
Abstract read
In one paragraphArticle in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Martin VališDepartment of Neurology, Faculty of Medicine and University Hospital Hradec Králové, Charles University in Prague, Sokolská 581, 500 05 Hradec Králové, Czech Republic. martin.valis@fnhk.cz.
Lukáš SobíšekDepartment of Neurology, Faculty of Medicine and University Hospital Hradec Králové, Charles University in Prague, Sokolská 581, 500 05 Hradec Králové, Czech Republic. lukas.sobisek@yahoo.com.ORCID 0000-0001-8071-2005 Oldřich VyšataDepartment of Neurology, Faculty of Medicine and University Hospital Hradec Králové, Charles University in Prague, Sokolská 581, 500 05 Hradec Králové, Czech Republic. oldrich.vysata@fnhk.cz.
Blanka KlímováDepartment of Neurology, Faculty of Medicine and University Hospital Hradec Králové, Charles University in Prague, Sokolská 581, 500 05 Hradec Králové, Czech Republic. Blanka.Klimova@uhk.cz.ORCID 0000-0001-8000-9766 Ctirad AndrýsDepartment of Clinical Immunology and Allergology, University Hospital Hradec Králové, Sokolská 581, 500 05 Hradec Králové, Czech Republic. ctirad.andrys@fnhk.cz.
Doris VokurkováDepartment of Clinical Immunology and Allergology, University Hospital Hradec Králové, Sokolská 581, 500 05 Hradec Králové, Czech Republic. doris.vokurkova@fnhk.cz.
Jiří MasopustDepartment of Neurology, Faculty of Medicine and University Hospital Hradec Králové, Charles University in Prague, Sokolská 581, 500 05 Hradec Králové, Czech Republic. jiri.masopust@fnhk.cz.
Zbyšek PavelekDepartment of Neurology, Faculty of Medicine and University Hospital Hradec Králové, Charles University in Prague, Sokolská 581, 500 05 Hradec Králové, Czech Republic. zbysekpavelek@email.cz.ORCID 0000-0002-1772-8781 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedAntigens, DifferentiationBiomarkersBiomarkers, PharmacologicalCohort StudiesDisease ProgressionFemaleGlatiramer AcetateHumansLeukocyte Common AntigensLymphocyte CountLymphocytesMaleMiddle AgedMultiple SclerosisAntigens, DifferentiationBiomarkersBiomarkers, PharmacologicalGlatiramer AcetateLeukocyte Common AntigensbiomarkerCD4+/CD45RO+disease progressionglatiramer acetatemultiple sclerosispatients
Identifiers
PMID31096621
PMCPMC6562382
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390